These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 15536354)

  • 1. [First-line treatment of metastatic non-small cell lung cancers].
    Pérol M
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S51-6. PubMed ID: 15536354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy for metastatic non-small cell lung cancer].
    Pérol M; Moro-Sibilot D
    Rev Mal Respir; 2005 Dec; 22(6 Pt 2):8S131-6. PubMed ID: 16340849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategy for treatment of metastatic non-small cell lung cancer.
    Berhoune M; Banu E; Scotte F; Prognon P; Oudard S; Bonan B
    Ann Pharmacother; 2008 Nov; 42(11):1640-52. PubMed ID: 18957625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
    Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
    Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature.
    Grossi F; Aita M; Follador A; Defferrari C; Brianti A; Sinaccio G; Belvedere O
    Oncologist; 2007 Apr; 12(4):451-64. PubMed ID: 17470688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New cytotoxics in the treatment of bronchial cancers].
    Quantin X; Godard P; Michel FB; Pujol JL
    Rev Mal Respir; 1998 Oct; 15(5):597-612. PubMed ID: 9834987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
    Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R
    Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches in chemotherapy of advanced and metastatic non-small cell lung cancer (NSCLC).
    Reck M
    Anticancer Res; 2005; 25(3A):1501-6. PubMed ID: 16033051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
    Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J
    Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
    Lorusso V; Gebbia V; Spada M; Guida M; Cassano G; Brunetti C; Germano D; Nettis G; Izzi G; Galetta D; Giampaglia M; Silvestris N; Colucci G
    Oncol Rep; 2005 Dec; 14(6):1547-51. PubMed ID: 16273254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
    J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stage IV NSCLC. Place of chemotherapy].
    Meert AP
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S107-12. PubMed ID: 18971834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach.
    Grossi F; Aita M; Defferrari C; Rosetti F; Brianti A; Fasola G; Vinante O; Pronzato P; Pappagallo G
    Oncologist; 2009 May; 14(5):497-510. PubMed ID: 19423674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stage IV non small cell bronchial carcinoma; first line therapy in 2007].
    Lemarié E
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S101-7. PubMed ID: 18235401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving patient management in metastatic non-small cell lung cancer.
    Vansteenkiste J
    Lung Cancer; 2007 Aug; 57 Suppl 2():S12-7. PubMed ID: 17686440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer].
    Quoix E
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S113-8. PubMed ID: 18971835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing first-line treatment options for patients with advanced NSCLC.
    Wakelee H; Belani CP
    Oncologist; 2005; 10 Suppl 3():1-10. PubMed ID: 16368866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.